SCHEMBL9954005

SCHEMBL9954005

Cc1cccc(C)c1-n1c(Cl)nc2ccc(I)cc2c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR1 Q9BXC0 1/20 0.40
CA12 O43570 3/20 0.39
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
CA9 Q16790 3/20 0.39
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PDE4D Q08499 1/20 0.38
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38
TUBA4A P68366 1/20 0.38
TUBB4B P68371 1/20 0.38
TUBB3 Q13509 1/20 0.38
TUBB2A Q13885 1/20 0.38
TUBB8 Q3ZCM7 1/20 0.38
TUBA3E Q6PEY2 1/20 0.38
TUBA1A Q71U36 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9954224 0.94 CDK9 (0.38) HCAR1CA12CA1CA2CA9
SCHEMBL9953497 0.84 PDE4D (0.43) HCAR1CA12CA1CA2CA9
SCHEMBL9954749 0.84 PDE7A (0.45) HCAR1PDE4D
SCHEMBL9953534 0.84 HCAR1 (0.43) HCAR1ALDH1A1LMNAL3MBTL1PDE4D
SCHEMBL9954830 0.82 HCAR1 (0.43) HCAR1CA12CA1CA2CA9
SCHEMBL9954457 0.81 HCAR1 (0.50) HCAR1CA12CA1CA2CA9
SCHEMBL9954100 0.80 SMN1; SMN2 (0.55) ALDH1A1LMNASMN1; SMN2
SCHEMBL9953965 0.80 POLB (0.41) CA12CA1CA2CA9TUBB4A
SCHEMBL9954234 0.80 ALDH1A1 (0.53) HCAR1ALDH1A1SMN1; SMN2
SCHEMBL9952976 0.78 LMNA (0.45) HCAR1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012087938-A1 QUINAZOLINONE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-06-28 WO disclosed
WO-2012087938-A1 QUINAZOLINONE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-06-28 WO disclosed